Boeing
BA
$234.15
+1.24%
The Boeing Company is a major global aerospace and defense firm operating across three core segments: commercial airplanes, defense, space & security, and global services. It is a duopolistic leader in the large commercial aircraft market alongside Airbus and a key prime contractor for U.S. defense and space programs. The current investor narrative is dominated by a high-stakes turnaround story, balancing severe reputational damage and operational challenges from a decade of safety failures against significant revenue catalysts from surging defense spending and a potential recovery in commercial airplane deliveries.…
BA
Boeing
$234.15
Related headlines
Investment Opinion: Should I buy BA Today?
Rating & Thesis: Hold. Boeing is a high-risk, high-potential turnaround story that is not yet investable for most due to its severe financial strain, but offers speculative appeal for those with a very high risk tolerance and a long time horizon. The bullish analyst consensus (multiple 'Buy' ratings) and average revenue target of $137.45 billion signal expected recovery, but the underlying fundamentals are too weak to support a Buy rating.
Supporting Evidence: The valuation, at a PS of 1.85 and EV/Sales of 2.23, is at a discount to its own history and some peers, pricing in significant distress. Q4 revenue growth of 57.11% YoY is a powerful positive signal. However, this is counteracted by a TTM operating margin of -6.05%, a debt-to-equity ratio of 9.98, and critically, negative TTM free cash flow of -$1.88 billion. The stock's 8.44% gain over the past month shows short-term momentum, but it remains down 9.81% over three months, reflecting persistent doubts.
Risks & Conditions: The two biggest risks are a liquidity crisis from prolonged negative cash flow and another major operational/safety setback that halts the delivery recovery. This Hold rating would upgrade to a Buy if the company demonstrates two consecutive quarters of sustained positive free cash flow and credible progress toward reducing leverage. It would downgrade to a Sell if quarterly revenue growth decelerates sharply (e.g., below 10% YoY) or if the debt-to-equity ratio worsens further. The stock is fairly valued relative to its current distressed state but would be undervalued only if the turnaround executes flawlessly—a low-probability scenario based on recent history.
Sign up to view all
BA 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The powerful revenue catalysts from defense and a potential commercial recovery are real, but they are squarely offset by the company's dire financial health, characterized by cash burn and extreme leverage. The stock is a binary bet on management's ability to engineer a financial turnaround faster than new operational problems emerge. The stance would upgrade to bullish on concrete evidence of sustained positive free cash flow for two quarters. It would downgrade to bearish on any indication that liquidity is becoming a pressing crisis, such as a dilutive equity offering or a covenant breach warning.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Boeing's 12-month outlook, with a consensus price target around $304.40 and implied upside of +30.0% versus the current price.
Average Target
$304.40
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$187 - $304
Analyst target range
Analyst coverage for Boeing is limited, with only 8 analysts providing estimates, which is unusually low for a company of its size and suggests some institutional caution or a wait-and-see approach amid the turmoil. The available data points to a bullish consensus sentiment, as evidenced by a series of recent 'Buy' or 'Outperform' ratings from major firms like Jefferies, UBS, Citigroup, and JP Morgan throughout January and February 2026. The average revenue estimate for the period is $137.45 billion, with a wide range from a low of $129.05 billion to a high of $148.35 billion. This wide target spread signals high uncertainty among analysts regarding the company's near-term financial performance, stemming from the unpredictable pace of the commercial delivery recovery, defense contract flows, and ongoing cost management. The pattern of reiterated bullish ratings in early 2026, despite negative news flow, indicates analyst conviction in the long-term turnaround story, but the limited number of contributors underscores the stock's contested and high-risk profile.
Bulls vs Bears: BA Investment Factors
The investment debate for Boeing is a classic high-stakes turnaround story where the bull case rests on powerful cyclical catalysts and the bear case highlights existential financial and operational flaws. Currently, the bear side presents stronger evidence due to the concrete, severe metrics of negative free cash flow, extreme leverage, and deeply negative operating margins. The single most important tension is the race between revenue recovery from defense contracts and commercial deliveries against the company's ability to translate that top-line growth into sustainable profitability and positive cash flow before its strained balance sheet triggers a crisis. The resolution of this cash burn versus revenue growth dynamic will ultimately determine the investment outcome.
Bullish
- Strong Defense Revenue Catalyst: The Pentagon has awarded Boeing a major contract to triple critical missile output, reinforcing a key growth segment. This comes amid a broader political push for defense primes to quadruple weaponry production, directly supporting the defense segment's revenue outlook.
- Significant Q4 Revenue Recovery: Q4 2025 revenue surged 57.11% year-over-year to $23.95 billion, a dramatic acceleration from $15.24 billion in Q4 2024. This indicates a potential inflection point in the commercial delivery and contract execution recovery, providing a tangible operational catalyst.
- Analyst Conviction in Turnaround: Despite limited coverage (only 8 analysts), major firms like Jefferies, UBS, and JP Morgan reiterated 'Buy' or 'Outperform' ratings in early 2026. This pattern of bullish sentiment amid negative news flow suggests institutional belief in the long-term recovery story.
- Valuation at Historical Discount: The stock trades at a Price-to-Sales (PS) ratio of 1.85, near the lower end of its multi-year historical range. This discounts severe operational risk but offers potential for substantial multiple expansion if the turnaround gains credible traction.
Bearish
- Severe Profitability & Margin Crisis: Profitability is deeply erratic, with Q4 2025 net income of $8.22B preceded by massive Q3 and Q2 losses. The TTM operating margin is -6.05% and the latest gross margin is only 7.57%, far below healthy industry standards, indicating unsustainable cost structures.
- Precarious Financial Health: The balance sheet is dangerously leveraged with a debt-to-equity ratio of 9.98. Critically, free cash flow over the TTM is negative $1.88 billion, meaning the company is burning cash and cannot internally fund operations or service its massive debt load.
- Persistent Safety & Quality Headwinds: A decade of safety failures continues to damage reputation and operations, as highlighted by NASA's scathing report on the Starliner, which suspended crewed flights. This introduces regulatory risk and potential contract losses exceeding $1 billion in the space segment.
- Volatile, Range-Bound Technicals: The stock is in a volatile consolidation, down 9.81% over 3 months despite a 37.97% 1-year gain. Trading at 52% of its 52-week range ($156.47-$254.35) with a beta of 1.128, it shows high volatility and a lack of clear directional conviction from the market.
BA Technical Analysis
The stock is in a volatile, range-bound consolidation phase following a significant downtrend. Over the past year, BA has gained 37.97%, but this masks a sharp 9.81% decline over the last three months. The current price of $223.38 sits at approximately 52% of its 52-week range ($156.47 to $254.35), indicating it is trading in the middle of its recent band, reflecting a market caught between recovery hopes and persistent operational headwinds. Recent momentum shows a short-term recovery attempt, with the stock up 8.44% over the past month, which diverges positively from the negative 3-month trend. This suggests a potential stabilization or mean reversion bounce from oversold conditions, though it has not yet reversed the intermediate-term downtrend. Key technical support is the 52-week low of $156.47, while immediate resistance is the 52-week high of $254.35. A sustained breakout above resistance would signal confidence in a full operational turnaround, while a breakdown below support would indicate a failure of the recovery thesis. With a beta of 1.128, the stock is approximately 13% more volatile than the broader market, which is significant for a large-cap industrial and warrants careful risk management in portfolios.
Beta
—
—
Max Drawdown
-25.2%
Largest decline past year
52-Week Range
$169-$254
Price range past year
Annual Return
+35.8%
Cumulative gain past year
| Period | BA Return | S&P 500 |
|---|---|---|
| 1m | +19.2% | +8.5% |
| 3m | -7.1% | +2.8% |
| 6m | +5.8% | +4.6% |
| 1y | +35.8% | +32.3% |
| ytd | +2.8% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BA Fundamental Analysis
Revenue growth has been volatile but showed a dramatic year-over-year surge of 57.11% in Q4 2025 to $23.95 billion, a significant acceleration from the $15.24 billion reported in Q4 2024. However, this follows several quarters of negative or low-single-digit growth, indicating a lumpy recovery trajectory heavily influenced by specific contract milestones and delivery schedules. Profitability remains deeply challenged; while Q4 2025 posted a net income of $8.22 billion, this was preceded by substantial losses in Q3 2025 (-$5.34 billion) and Q2 2025 (-$611 million). The gross margin of 7.57% in the latest quarter and an operating margin of -6.05% (TTM) highlight severe ongoing cost pressures and inefficiencies, far below healthy industry standards. The balance sheet and cash flow situation is precarious. The company carries an extremely high debt-to-equity ratio of 9.98, indicating a heavily leveraged capital structure. Critically, free cash flow over the trailing twelve months is negative $1.88 billion, demonstrating the company is not generating sufficient internal cash to fund operations and service its debt, relying on external financing. The current ratio of 1.19 suggests adequate short-term liquidity, but the overarching financial health is strained.
Quarterly Revenue
$23.9B
2025-12
Revenue YoY Growth
+0.57%
YoY Comparison
Gross Margin
+0.07%
Latest Quarter
Free Cash Flow
$-1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BA Overvalued?
Given the company's erratic profitability, we lead with the Price-to-Sales (PS) ratio, as net income has been volatile and recently positive but not yet indicative of a sustainable earnings stream. Boeing trades at a trailing PS ratio of 1.85 and an EV/Sales of 2.23. Compared to the broader Aerospace & Defense industry, which often trades at higher sales multiples due to stable defense contracts, Boeing's PS ratio appears at a discount, reflecting the elevated risk and operational uncertainty priced into the stock. Historically, Boeing's own valuation tells a story of distress and potential recovery. The current PS ratio of 1.85 is near the lower end of its multi-year historical range, which has seen extreme swings into negative territory for earnings-based multiples. Trading near historical lows suggests the market is pricing in significant fundamental deterioration, but it also may represent a value opportunity if the turnaround gains credible traction, as even a partial recovery towards historical norms could imply substantial multiple expansion.
PE
74.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -1629x~106x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
28.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on Boeing's unsustainable capital structure and cash burn. The company's debt-to-equity ratio of 9.98 indicates extreme financial leverage, while negative TTM free cash flow of -$1.88 billion demonstrates an inability to self-fund. Profitability is wildly volatile, with an operating margin of -6.05% and a gross margin of just 7.57% in the latest quarter, showing the company is far from achieving operational efficiency. Revenue, while showing a strong Q4 surge of 57.11%, remains lumpy and heavily dependent on specific contract milestones and delivery resumptions, creating earnings visibility risk.
Market & Competitive Risks include valuation compression if the operational turnaround stalls. While the current PS ratio of 1.85 appears discounted, it reflects high risk; failure to improve margins could lead to further multiple contraction. Geopolitical rhetoric, such as potential NATO exit discussions, introduces headline volatility for the defense segment despite strong contract flows. The company also faces intense duopolistic competition with Airbus in commercial and with Lockheed and Northrop in defense, limiting pricing power. The stock's beta of 1.128 indicates it is 13% more volatile than the market, amplifying downside during broader sell-offs.
Worst-Case Scenario involves a 'failure of the turnaround' where persistent safety issues trigger new regulatory groundings or contract cancellations, while cost overruns prevent margin improvement. This could lead to a liquidity crisis as negative cash flow persists, forcing dilutive equity raises or debt restructuring. The realistic downside is significant, referencing the 52-week low of $156.47, which represents a potential loss of approximately -30% from the current price of $223.38. A re-test of this low, driven by a major earnings miss or a new safety scandal, is a plausible adverse scenario given the stock's historical volatility and current fundamental fragility.
FAQ
The key risks are, in order of severity: 1) Financial Risk: The company is burning cash (-$1.88B TTM FCF) and is extremely leveraged (Debt/Equity: 9.98), risking a liquidity crisis. 2) Operational Risk: A decade of safety failures continues, with potential for new incidents, groundings, or contract cancellations (e.g., NASA Starliner). 3) Execution Risk: The company must translate strong defense revenue and recovering commercial deliveries into sustained profitability, which it has failed to do consistently. 4) Macro & Geopolitical Risk: The stock's beta of 1.128 makes it sensitive to market downturns, and defense spending can be politically volatile.
The 12-month forecast is highly bifurcated, with three distinct scenarios. The Base Case (50% probability) sees a range-bound stock between $200 and $240, as the company shows uneven progress. The Bull Case (25% probability) could drive the stock to $254-$280 on a successful turnaround and multiple expansion. The Bear Case (25% probability) could see a re-test of the 52-week low near $156 if operational or financial conditions deteriorate. The Base Case is most likely, reflecting the high uncertainty and the grinding nature of the expected recovery, where positive news is met with skepticism due to the weak balance sheet.
BA is fairly valued relative to its current distressed state but would be undervalued if the turnaround executes. The primary valuation metric, the Price-to-Sales (PS) ratio of 1.85, is near the low end of its historical range, indicating the market is pricing in significant operational risk and poor profitability (TTM operating margin of -6.05%). Compared to healthier aerospace & defense peers, this is a discount, but it is justified by Boeing's unique challenges. The valuation implies the market expects a prolonged and uncertain recovery, with a high probability of further setbacks.
BA is a high-risk, speculative buy only suitable for investors with a very high risk tolerance and a long-term horizon. The bullish case, supported by a 57.11% Q4 revenue surge and major defense contracts, offers significant upside if the turnaround succeeds. However, the severe bear case, evidenced by negative $1.88B free cash flow and a 9.98 debt-to-equity ratio, presents a real risk of permanent capital loss. For most investors, it is not a 'good buy' given the existential financial risks, but it may represent a calculated speculation for those who believe management can navigate the company back to stability.
BA is strictly a long-term, multi-year investment for those betting on the turnaround. The company's deep-seated operational and financial issues cannot be resolved in quarters. The stock's high beta (1.128) and recent 25%+ drawdowns make it far too volatile and unpredictable for short-term trading. There is no meaningful dividend (yield 0.2%) to support a holding period. Investors should be prepared to hold for a minimum of 3-5 years to see if the recovery narrative plays out, acknowledging the high risk of permanent impairment along the way.